Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

143.85
Delayed Data
As of May 27
 +0.73 / +0.51%
Today’s Change
127.10
Today|||52-Week Range
242.37
-25.06%
Year-to-Date
Is Cancer the Biggest Opportunity Ahead for Illumina, Inc.?
May 26 / MotleyFool.com - Paid Partner Content
Baron Funds Comments on Illumina Inc.
May 23 / GuruFocus News - Paid Partner Content
New Strong Sell Stocks for May 26th
May 26 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close143.12
Today’s open143.47
Day’s range141.70 - 144.50
Volume659,750
Average volume (3 months)1,511,311
Market cap$21.2B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+2.06%
Earnings growth (next 5 years)+13.75%
Revenue growth (last year)+19.25%
P/E ratio51.7
Price/Sales12.89
Price/Book11.41

Competitors

 Today’s
change
Today’s
% change
AAgilent Technologies...+0.31+0.68%
WATWaters Corp+0.74+0.54%
MTDMettler-Toledo Inter...+1.42+0.38%
PKIPerkinElmer Inc+0.02+0.04%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$0.74
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jay T. Flatley
President &
Director
Francis A. deSouza
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs